Veterinary vaccines market
Veterinary Vaccines Market, By Animal Type (Companion, Livestock), By Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, Subunit and DNA Vaccines, and Recombinant Vaccines), By Route of Administration (Subcutaneous Injection, Intramuscular Injection, Intranasal Administration, and Others), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Mar 2024
- CMI125
- 220 Pages
- Excel & Pdf
- Pharmaceutical
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Animal Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- PEST Analysis
- Market Dynamics
- Global Veterinary Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the Market
- Global Veterinary Vaccine Market, By Technology, 2019 – 2031, (US$ Billion)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Inactivated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Toxoid Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Live Attenuated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Subunit and DNA Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Recombinant Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Overview
- Global Veterinary Vaccine Market, By Animal Type, 2019 – 2031, (US$ Billion)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Companion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Equine
- Canine
- Feline
- Livestock
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Bovine
- Ovine
- Porcine
- Poultry
- Others
- Overview
- Global Veterinary Vaccine Market, By Route of Administration, 2019 – 2031, (US$ Billion)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Subcutaneous Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Intramuscular Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Intranasal Administration
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Overview
- Global Veterinary Vaccine Market, By Distribution Channel, 2019 – 2031, (US$ Billion)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Overview
- Global Veterinary Vaccine Market, By Region, 2019 – 2031, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019–2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (US$ Billion)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Aratana Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneus Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Morphogenesis, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Karyopharm Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zoetis, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aratana Therapeutics, Inc.
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
Segmentation
Market Segmentation
- Technology:
- Inactivated Vaccines
- Toxoid Vaccines
- Live Attenuated Vaccines
- Subunit and DNA Vaccines
- Recombinant Vaccines
- Animal Type:
- Companion
- Equine
- Canine
- Feline
- Livestock
- Bovine
- Ovine
- Porcine
- Poultry
- Others
- Companion
- Route of Administration:
- Subcutaneous Injection
- Intramuscular Injection
- Intranasal Administration
- Others
- Distribution Channel
- Public
- Private
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Frequently Asked Questions -
What will be the CAGR of the veterinary vaccines market?
The CAGR of the veterinary vaccines market is projected to be 7.6% from 2024 to 2031.
What are the major factors driving the veterinary vaccines market growth?
Increasing government initiatives for veterinary vaccine and expanding veterinary healthcare infrastructure are the major factors driving the growth of the veterinary vaccines market.
What are the key factors hampering the growth of the veterinary vaccines market?
High storage costs and stringent government regulations are the major factors hampering the growth of the veterinary vaccines market.
Which is the leading animal type in the veterinary vaccines market?
In terms of animal type, livestock is estimated to dominate the market revenue share in 2024.
Which are the major players operating in the veterinary vaccines market?
Aratana Therapeutics Inc., Regeneus Ltd., Morphogenesis Inc., Karyopharm Therapeutics Inc., Zoetis Inc., Eli Lilly and Company, Merck & Co. Inc., Boehringer Ingelheim GmbH., Elanco Animal Health, Virbac, Hester Biosciences Limited, Ceva Sante Animale, Phibro Animal Health Corporation, Kemin Industries, Inc., Finlab, Vaxxinova, Vira Vaccine Shaya, and VETERQUIMICA SA are the major players operating in the market.
Which region will lead the veterinary vaccines market?
North America is expected to lead the veterinary vaccines market.